PDS Biotechnology PDSB Income Statement (2014-2026)

NASDAQ PDSB
$0.21 +0.01 (+5.00%)
At close: Aug 20, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Income Statement Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Shares Outstanding (Entity) (Quarter)
23.16M28.44M28.45M28.45M28.46M28.46M30.17M30.72M30.87M31.01M33.09M36.68M36.78M36.82M37.99M45.45M46.63M47.71M54.88M55.92M
Operating items
Research & Development (Quarter)
2.76M3.69M3.39M5.16M3.76M4.35M16.16M5.84M8.00M6.45M7.47M6.70M4.53M6.80M4.53M5.83M4.21M4.58M4.41M3.27M
Wages, Salaries and Other (Quarter)
4.18M1.69M0.88M2.81M1.13M2.86M3.66M1.08M3.38M
Selling, General & Administrative (Quarter)
2.34M3.27M2.93M3.32M3.33M2.93M2.67M3.58M4.69M4.07M2.94M3.39M4.16M3.37M2.83M3.27M3.41M3.56M2.27M3.23M
Restructuring Costs (Quarter)
0.36M0.38M0.35M0.34M0.34M0.39M0.36M0.36M0.31M
Other Operating Expenses (Quarter)
-0.36M-0.38M-0.35M-0.34M-0.34M-0.39M-0.36M-0.36M-0.31M
Operating Expenses (Quarter)
5.11M6.96M6.32M8.48M7.09M7.28M18.82M9.42M12.70M10.52M10.41M10.10M8.68M10.18M7.36M9.11M7.62M8.14M6.67M6.50M
Operating Income (Quarter)
-5.11M-6.96M-6.32M-8.48M-7.09M-7.28M-18.82M-9.42M-12.70M-10.52M-10.41M-10.10M-8.68M-10.18M-7.36M-9.11M-7.62M-8.14M-6.67M-6.50M
EBIT (Quarter)
-5.11M-6.96M-6.32M-8.48M-7.09M-7.28M-18.82M-9.42M-12.70M-10.52M-10.41M-10.10M-8.68M-10.18M-7.36M-9.11M-7.62M-8.14M-6.67M-6.50M
Non-operating items
Interest & Investment Income (Quarter)
604.000.00M0.00M0.01M0.07M0.25M0.60M0.73M0.75M0.74M0.68M0.67M0.68M0.67M0.50M0.38M0.33M0.28M0.22M0.13M
Other Non Operating Income (Quarter)
Non Operating Income (Quarter)
0.00M0.00M0.01M0.07M-0.15M-0.32M-0.24M-0.24M-0.33M-0.49M-0.51M-0.51M-0.55M-0.59M-0.55M-1.81M-0.87M-0.89M-3.25M
Net income details
EBT (Quarter)
-5.11M-6.96M-6.32M-14.92M-7.02M-7.42M-19.14M-9.66M-12.94M-10.85M-10.90M-10.60M-9.20M-10.73M-7.95M-9.66M-9.43M-9.01M-7.56M-9.75M
Tax Provisions (Quarter)
-4.52M-1.20M0.00M-1.41M2.00-0.87M-1.17M-7.49M
Profit After Tax (Quarter)
-0.59M-6.96M-6.32M-8.47M-5.82M-7.42M-19.14M-9.66M-11.53M-10.85M-10.90M-10.60M-8.33M-10.73M-7.95M-8.49M-9.43M-9.01M-7.56M-9.75M
Income from Continuing Operations (Quarter)
-0.59M-6.96M-6.32M-14.92M-5.82M-7.42M-19.14M-9.66M-11.53M-10.85M-10.90M-10.60M-8.33M-10.73M-7.95M-8.49M-9.43M-9.01M-0.07M-9.75M
Consolidated Net Income (Quarter)
-0.59M-6.96M-6.32M-14.92M-5.82M-7.42M-19.14M-9.66M-11.53M-10.85M-10.90M-10.60M-8.33M-10.73M-7.95M-8.49M-9.43M-9.01M-0.07M-9.75M
Income towards Parent Company (Quarter)
-0.59M-6.96M-6.32M-14.92M-5.82M-7.42M-19.14M-9.66M-11.53M-10.85M-10.90M-10.60M-8.33M-10.73M-7.95M-8.49M-9.43M-9.01M-0.07M-9.75M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)
-0.59M-6.96M-6.32M-14.92M-5.82M-7.42M-19.14M-9.66M-11.53M-10.85M-10.90M-10.60M-8.33M-10.73M-7.95M-8.49M-9.43M-9.01M-0.07M-9.75M
Additional items
EPS (Basic) (Quarter)
-0.03-0.24-0.25-0.57-0.20-0.26-0.67-0.32-0.37-0.35-0.35-0.30-0.23-0.29-0.22-0.21-0.21-0.190.00-0.18
EPS (Diluted) (Quarter)
-0.03-0.24-0.25-0.57-0.20-0.26-0.67-0.32-0.37-0.35-0.35-0.30-0.23-0.29-0.22-0.21-0.21-0.190.00-0.18
Shares Outstanding (Quarter)
23.16M28.43M25.60M26.16M28.45M28.46M28.60M30.43M30.80M30.91M30.95M34.82M36.69M36.81M36.45M40.52M45.90M46.87M46.38M55.66M
Shares Outstanding (Diluted) (Quarter)
23.16M28.43M25.60M26.16M28.45M28.46M28.60M30.43M30.80M30.91M30.95M34.82M36.69M36.81M36.45M40.52M45.90M46.87M46.38M55.66M
EBITDA (Quarter)
-5.11M-6.96M-6.32M-8.48M-7.09M-7.28M-18.82M-9.42M-12.70M-10.52M-10.41M-10.10M-8.68M-10.18M-7.36M-9.11M-7.62M-8.14M-6.67M-6.50M
Interest Expenses (Quarter)
25.36M29.75M0.04M6.45M2.16M1.13M0.45M0.97M4.65M4.69M1.17M1.17M1.19M2.16M-0.02M0.93M2.14M1.15M3.05M3.38M
Tax Rate (Quarter)
88.4617.08-0.0110.860.009.4512.1199.03